MET Copy Number Gain Associates with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR Mutant Lung Cancer

被引：1
|
作者：
Yano, Seiji [1 ]
Nanjo, Shigeki [1 ]
Arai, Sachiko [1 ]
Takeuchi, Shinji [1 ]
Yamada, Tadaaki [1 ]
Okada, Yasunori [2 ]
Hata, Akito [3 ]
Katakami, Nobuyuki [3 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan
[2] Juntendo Univ, Tokyo, Japan
[3] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
CNS Metastasis; osimertinib; MET copy number gain; EGFR-TKI resistance;
D O I：
10.1016/j.jtho.2016.11.269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA08.03
引用
收藏
页码：S272 / S273
页数：2
相关论文
共 50 条
  • [41] Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
    Uruga, Hironori
    Moriguchi, Shuhei
    Takahashi, Yui
    Ogawa, Kazumasa
    Murase, Kyoko
    Mochizuki, Sayaka
    Hanada, Shigeo
    Takaya, Hisashi
    Miyamoto, Atsushi
    Morokawa, Nasa
    Kishi, Kazuma
    BMC CANCER, 2018, 18
  • [42] Overcoming ARID1A mutation-induced osimertinib resistance in EGFR-mutant NSCLC leptomeningeal carcinomatosis
    Fukuda, Koji
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Yano, Seiji
    CANCER SCIENCE, 2024, 115 : 112 - 112
  • [43] EGFRvIII mutation in lung cancer correlates with increased EGFR copy number
    Sasaki, Hidefumi
    Kawano, Osamu
    Endo, Katsuhiko
    Yukiue, Haruhiro
    Yano, Motoki
    Fujii, Yoshitaka
    ONCOLOGY REPORTS, 2007, 17 (02) : 319 - 323
  • [44] Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinib
    Zheng, Xuanxuan
    Zhang, Guowei
    Li, Peng
    Zhang, Mina
    Yan, Xiangtao
    Zhang, Xiaojuan
    Yang, Jinbo
    Li, Haixia
    Liu, Xiyang
    Ma, Zhiyong
    Wang, Huijuan
    LUNG CANCER, 2019, 129 : 72 - 74
  • [45] Acquired resistance to gefitinib is associated with cancer stem-like phenotype and EMT in EGFR mutant lung adenocarcinoma.
    Lim, Sun Min
    Kim, Hyun Jung
    Ban, Young Ho
    Ha, Sang Jun
    Cho, Byoung Chui
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Icotinib for Control of Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer with Sensitive EGFR Mutations
    Fan, Yun
    Gong, Lei
    Huang, Zhiyu
    Miao, Lulu
    Xu, Yanjun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S648 - S648
  • [47] IL-6 dynamics regulate neuroendocrine transformation in gefitinib acquired resistance EGFR mutant lung cancer cells
    Wu, Shang-Yin
    Yeh, Hsuan-Heng
    Hung, Chun-Hua
    Lin, Chien-Chung
    Su, Wen-Pin
    Su, Wu-Chou
    CANCER RESEARCH, 2017, 77
  • [48] Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer
    Takeuchi, Shinji
    Wang, Wei
    Li, Qi
    Yamada, Tadaaki
    Kita, Kenji
    Donev, Ivan S.
    Nakamura, Takahiro
    Matsumoto, Kunio
    Shimizu, Eiji
    Nishioka, Yasuhiko
    Sone, Saburo
    Nakagawa, Takayuki
    Uenaka, Toshimitsu
    Yano, Seiji
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (03): : 1034 - 1043
  • [49] MET gene copy number heterogeneity in non-small cell lung cancer patients resistant to EGFR-TKIs
    Bai, Q.
    Chen, Y.
    Xiao, X.
    Chang, H.
    Xin, B.
    Jia, L.
    Li, J.
    Wang, Z.
    Yu, C.
    Xiong, H.
    Zhou, X.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S150 - S151
  • [50] Phase I study of high dose gefitinib in patients with leptomeningeal metastases from EGFR-mutant non-small cell lung cancer
    Jackman, David M.
    Kesari, Santosh
    Cioffredi, Leigh-Anne
    Sequist, Lecia V.
    Rabin, Michael S.
    Lynch, Thomas J.
    Marcoux, J. P.
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S685 - S685
12345